XNYS · Healthcare · Medical Devices
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Q1 2026 | 0.73 | 0.78 | +6.85% | $1.65B | ✅ Beat | +4.73% | +4.74% | +7.60% |
| 2026-02-10 | Q4 2025 | 0.62 | 0.58 | -6.45% | $1.57B | ❌ Miss | +1.56% | +1.82% | +9.81% |
| 2025-10-30 |
| Q3 2025 |
| 0.59 |
| 0.67 |
| +13.56% |
| $1.55B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-04-23 | Q1 2025 | 0.60 | 0.64 | +6.67% | $1.41B | ✅ Beat | +6.63% | +7.14% | +6.43% |
| 2025-02-11 | Q4 2024 | 0.55 | 0.59 | +7.27% | $1.39B | ✅ Beat | +6.92% | +6.71% | -4.17% |
| 2024-10-24 | Q3 2024 | 0.64 | 0.67 | +4.69% | $1.35B | ✅ Beat | -1.38% | -4.75% | +1.31% |
| 2024-07-24 | Q2 2024 | 0.69 | 0.70 | +1.45% | $1.63B | ✅ Beat | -31.34% | -27.49% | -18.48% |
| 2024-04-25 | Q1 2024 | 0.64 | 0.66 | +3.12% | $1.60B | ✅ Beat | -1.80% | -3.35% | -1.10% |
Showing last 8 quarters.